Julia Nilsson, Research Associate at InfiCure Bio, will be presenting at the Keystone Symposium: "Integrated Pathways of Disease in NASH and NAFLD" in Santa Fee January 20-24 2019. Julia will present new data on the NIF mouse as a model for late inflammatory/fibrotic stage of NASH.

The CEO of InfiCure Bio was one of 28 Expert Speakers at the Anti-Fibrotic Drug Development Summit held in Boston November 27-29 2018. InfiCure Bio was presenting new data on the unique NIF mouse as well as data on models for NASH and kidney fibrosis under development.